PTPN22 controls virally-induced autoimmune diabetes by modulating cytotoxic T lymphocyte responses in an epitope-specific manner

Georgia Fousteri, Tatiana Jofra, Roberta Di Fonte, Mirela Kuka, Matteo Iannacone, Manuela Battaglia

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Ptpn22 is one of the most potent autoimmunity predisposing genes and strongly associates with type 1 diabetes (T1D). Previous studies showed that non-obese diabetic mice with reduced expression levels of Ptpn22 are protected from T1D due to increased number of T regulatory (Treg) cells. We report that lack of Ptpn22 exacerbates virally-induced T1D in female rat insulin promoter lymphocytic choriomeningitis virus (RIP-LCMV-GP) mice, while maintaining higher number of Treg cells throughout the antiviral response in the blood and spleen but not in the pancreatic lymph nodes. GP33-41-specific pentamer-positive cytotoxic lymphocytes (CTLs) are numerically reduced in the absence of Ptpn22 at the expansion and contraction phase but reach wild-type levels at the memory phase. However, they show similar effector function and even a subtle increase in the production of IL-2. In contrast, NP396-404-specific CTLs develop normally at all phases but display enhanced effector function. Lack of Ptpn22 also augments the memory proinflammatory response of GP61-80 CD4 T cells. Hence, lack of Ptpn22 largely augments antiviral effector T cell responses, suggesting that caution should be taken when targeting Ptpn22 to treat autoimmune diseases where viral infections are considered environmental triggers.

Original languageEnglish
Pages (from-to)98-108
Number of pages11
JournalClinical Immunology
Volume156
Issue number2
DOIs
Publication statusPublished - Feb 1 2015

Fingerprint

Cytotoxic T-Lymphocytes
Type 1 Diabetes Mellitus
Lymphocytic choriomeningitis virus
Epitopes
Regulatory T-Lymphocytes
Antiviral Agents
Lymphocytes
T-Lymphocytes
Inbred NOD Mouse
Virus Diseases
Autoimmunity
Autoimmune Diseases
Interleukin-2
Spleen
Lymph Nodes
Insulin
Genes

Keywords

  • Cytotoxic lymphocytes (CTLs);
  • Memory CD8<sup>+</sup> T cells;
  • Ptpn22;
  • Treg cells
  • Type 1 diabetes (T1D);
  • Virally-induced T1D;

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy
  • Medicine(all)

Cite this

PTPN22 controls virally-induced autoimmune diabetes by modulating cytotoxic T lymphocyte responses in an epitope-specific manner. / Fousteri, Georgia; Jofra, Tatiana; Di Fonte, Roberta; Kuka, Mirela; Iannacone, Matteo; Battaglia, Manuela.

In: Clinical Immunology, Vol. 156, No. 2, 01.02.2015, p. 98-108.

Research output: Contribution to journalArticle

@article{68411700803f4aea834965fff9dc5f36,
title = "PTPN22 controls virally-induced autoimmune diabetes by modulating cytotoxic T lymphocyte responses in an epitope-specific manner",
abstract = "Ptpn22 is one of the most potent autoimmunity predisposing genes and strongly associates with type 1 diabetes (T1D). Previous studies showed that non-obese diabetic mice with reduced expression levels of Ptpn22 are protected from T1D due to increased number of T regulatory (Treg) cells. We report that lack of Ptpn22 exacerbates virally-induced T1D in female rat insulin promoter lymphocytic choriomeningitis virus (RIP-LCMV-GP) mice, while maintaining higher number of Treg cells throughout the antiviral response in the blood and spleen but not in the pancreatic lymph nodes. GP33-41-specific pentamer-positive cytotoxic lymphocytes (CTLs) are numerically reduced in the absence of Ptpn22 at the expansion and contraction phase but reach wild-type levels at the memory phase. However, they show similar effector function and even a subtle increase in the production of IL-2. In contrast, NP396-404-specific CTLs develop normally at all phases but display enhanced effector function. Lack of Ptpn22 also augments the memory proinflammatory response of GP61-80 CD4 T cells. Hence, lack of Ptpn22 largely augments antiviral effector T cell responses, suggesting that caution should be taken when targeting Ptpn22 to treat autoimmune diseases where viral infections are considered environmental triggers.",
keywords = "Cytotoxic lymphocytes (CTLs);, Memory CD8<sup>+</sup> T cells;, Ptpn22;, Treg cells, Type 1 diabetes (T1D);, Virally-induced T1D;",
author = "Georgia Fousteri and Tatiana Jofra and {Di Fonte}, Roberta and Mirela Kuka and Matteo Iannacone and Manuela Battaglia",
year = "2015",
month = "2",
day = "1",
doi = "10.1016/j.clim.2014.12.002",
language = "English",
volume = "156",
pages = "98--108",
journal = "Clinical Immunology",
issn = "1521-6616",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - PTPN22 controls virally-induced autoimmune diabetes by modulating cytotoxic T lymphocyte responses in an epitope-specific manner

AU - Fousteri, Georgia

AU - Jofra, Tatiana

AU - Di Fonte, Roberta

AU - Kuka, Mirela

AU - Iannacone, Matteo

AU - Battaglia, Manuela

PY - 2015/2/1

Y1 - 2015/2/1

N2 - Ptpn22 is one of the most potent autoimmunity predisposing genes and strongly associates with type 1 diabetes (T1D). Previous studies showed that non-obese diabetic mice with reduced expression levels of Ptpn22 are protected from T1D due to increased number of T regulatory (Treg) cells. We report that lack of Ptpn22 exacerbates virally-induced T1D in female rat insulin promoter lymphocytic choriomeningitis virus (RIP-LCMV-GP) mice, while maintaining higher number of Treg cells throughout the antiviral response in the blood and spleen but not in the pancreatic lymph nodes. GP33-41-specific pentamer-positive cytotoxic lymphocytes (CTLs) are numerically reduced in the absence of Ptpn22 at the expansion and contraction phase but reach wild-type levels at the memory phase. However, they show similar effector function and even a subtle increase in the production of IL-2. In contrast, NP396-404-specific CTLs develop normally at all phases but display enhanced effector function. Lack of Ptpn22 also augments the memory proinflammatory response of GP61-80 CD4 T cells. Hence, lack of Ptpn22 largely augments antiviral effector T cell responses, suggesting that caution should be taken when targeting Ptpn22 to treat autoimmune diseases where viral infections are considered environmental triggers.

AB - Ptpn22 is one of the most potent autoimmunity predisposing genes and strongly associates with type 1 diabetes (T1D). Previous studies showed that non-obese diabetic mice with reduced expression levels of Ptpn22 are protected from T1D due to increased number of T regulatory (Treg) cells. We report that lack of Ptpn22 exacerbates virally-induced T1D in female rat insulin promoter lymphocytic choriomeningitis virus (RIP-LCMV-GP) mice, while maintaining higher number of Treg cells throughout the antiviral response in the blood and spleen but not in the pancreatic lymph nodes. GP33-41-specific pentamer-positive cytotoxic lymphocytes (CTLs) are numerically reduced in the absence of Ptpn22 at the expansion and contraction phase but reach wild-type levels at the memory phase. However, they show similar effector function and even a subtle increase in the production of IL-2. In contrast, NP396-404-specific CTLs develop normally at all phases but display enhanced effector function. Lack of Ptpn22 also augments the memory proinflammatory response of GP61-80 CD4 T cells. Hence, lack of Ptpn22 largely augments antiviral effector T cell responses, suggesting that caution should be taken when targeting Ptpn22 to treat autoimmune diseases where viral infections are considered environmental triggers.

KW - Cytotoxic lymphocytes (CTLs);

KW - Memory CD8<sup>+</sup> T cells;

KW - Ptpn22;

KW - Treg cells

KW - Type 1 diabetes (T1D);

KW - Virally-induced T1D;

UR - http://www.scopus.com/inward/record.url?scp=84919934960&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84919934960&partnerID=8YFLogxK

U2 - 10.1016/j.clim.2014.12.002

DO - 10.1016/j.clim.2014.12.002

M3 - Article

C2 - 25513733

AN - SCOPUS:84919934960

VL - 156

SP - 98

EP - 108

JO - Clinical Immunology

JF - Clinical Immunology

SN - 1521-6616

IS - 2

ER -